BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/30/2023 12:54:07 PM | Browse: 131 | Download: 280
 |
Received |
|
2023-03-22 06:33 |
|
Peer-Review Started |
|
2023-03-22 06:36 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2023-05-13 03:16 |
|
Revised |
|
2023-05-16 12:48 |
|
Second Decision |
|
2023-06-02 03:11 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2023-06-02 08:03 |
|
Articles in Press |
|
2023-06-02 08:03 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2023-06-25 01:50 |
|
Publish the Manuscript Online |
|
2023-06-30 12:54 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Emergency Medicine |
| Manuscript Type |
Randomized Controlled Trial |
| Article Title |
Ulinastatin in the treatment of severe acute pancreatitis: A single-center randomized controlled trial
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Su-Qin Wang, Wei Jiao, Jing Zhang, Ju-Fen Zhang, Yun-Na Tao, Qing Jiang and Feng Yu |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Wuxi Science and Technology Development Fund |
WX03-02B0205-072001-10 |
|
| Corresponding Author |
Feng Yu, MM, Doctor, Department of General Surgery, The 904th Hospital of Joint Logistic Support Force, No. 101 Xing Yuan North Road, Wuxi 214044, Jiangsu Province, China. yufeng904@21cn.com |
| Key Words |
Ulinastatin; 7-day mortality; Severe acute pancreatitis; Randomized controlled trial; Outcome |
| Core Tip |
One of the most prevalent gastrointestinal tract GI disorders, severe acute pancreatitis (AP), is the leading cause of hospitalization due to gastrointestinal diseases. The present study suggests that ulinastatin (UTI) can reduce the risk of overall 7-d mortality in severe AP patients and is associated with a higher total effective rate vs the placebo control group. We also found that UTI can protect against hyperinflammation. It also did not significantly increase the incidence rate of severe adverse effects. |
| Publish Date |
2023-06-30 12:54 |
| Citation |
Wang SQ, Jiao W, Zhang J, Zhang JF, Tao YN, Jiang Q, Yu F. Ulinastatin in the treatment of severe acute pancreatitis: A single-center randomized controlled trial. World J Clin Cases 2023; 11(19): 4601-4611 |
| URL |
https://www.wjgnet.com/2307-8960/full/v11/i19/4601.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v11.i19.4601 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
